Protagonist Therapeutics Inc, created in 2000 (United States), from 2214 competing brands. Protagonist Therapeutics Inc is owned by Protagonist Therapeutics Inc, listed on the stock exchange of New York Protagonist Therapeutics Inc belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Protagonist Therapeutics Inc
over 5 years*
USD 59.24